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Adipose tissue metabolism and circulation play an important role in human health. It is 
well-known that adipose tissue mass is increased in response to excess caloric intake 
leading to obesity and further to local hypoxia and inflammatory signaling. Acute exer-
cise increases blood supply to adipose tissue and mobilization of fat stores for energy. 
However, acute exercise during systemic hypoxia reduces subcutaneous blood flow in 
healthy young subjects, but the response in overweight or obese subjects remains to 
be investigated. Emerging evidence also indicates that exercise training during hypoxic 
exposure may provide additive benefits with respect to many traditional cardiovascular 
risk factors as compared to exercise performed in normoxia, but unfavorable effects of 
hypoxia have also been documented. These topics will be covered in this brief review 
dealing with hypoxia and adipose tissue physiology.
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GeneRAL CARDiOvASCULAR AnD MeTABOLiC  
ReSPOnSeS TO HYPOXiA
A large body of knowledge on the physiological effects of hypoxia has been obtained over several 
decades from field experiments in the mountains as well as from studies in environmental cham-
bers, where ambient air is manipulated. Hypoxia, defined as reduced or insufficient oxygen supply 
caused by reduced oxygen saturation of arterial blood, results in cardiovascular system adjustments 
to deliver more blood to tissues to compensate for reduced oxygen delivery, which is sensed by 
oxygen-sensing mechanisms, such as carotid bodies (1). The acute central cardiovascular response 
to hypoxic stress triggers an increased heart rate at an unchanged stroke volume mediated primarily 
by increased sympathetic neural discharge as a function of increasing hypoxic severity. At rest, 
lower levels of hypoxic exposure may result in some degree of systemic vasodilation, while with 
increasing severity of hypoxia, the peripheral vasculature constricts to redistribute oxygen delivery 
to the most critically dependent organs, e.g., heart (2–5), brain (6–8) needs to be ensured. This 
regulation is exacerbated in obstructive sleep apnea, which creates a physiological condition called 
chronic intermittent hypoxia, which may compromise some functions of the body. Similarly, dur-
ing exercise in hypoxia, perfusion of skeletal muscle is increased to match oxygen demand, which 
creates circulatory competition between the locomotor skeletal muscles and other organs, and leads 
to decreased exercise capacity with severity of hypoxia.
In addition to cardiovascular stress, hypoxia also alters energy metabolism of the body 
(Figure 1). Although hypoxia might theoretically even slightly decrease the oxygen requirements 
FiGURe 1 | The effects of obesity, acute exercise, hypoxic or altitude exposure, and endurance training on adipose tissue, such as subcutaneous 
adipose tissue, surrounding thigh musculature as illustrated by the fusion image in the middle of the figure obtained by combining magnetic 
resonance and positron emission tomography imaging. Obesity induces negative (red arrow) inflammatory state in adipose tissue connected with capillary 
rarefaction and local hypoxia. Acute low or moderate intensity exercise is on the other hand capable of increasing adipose tissue blood flow and metabolism, which, 
in the long run, reduces adipose tissue cell size and inflammation. This effect may be potentiated by hypoxic exposure or altitude training, but scientific evidence is 
still in its infancy to prove this hypothesis correct. It also remains to be investigated to what extent classical endurance training can affect adipose tissue blood flow 
and metabolism in humans.
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at the local tissue level due to reduced oxygen supply, increased 
sympathetic neural activation and resulting release of vari-
ous stress hormones often cause whole body metabolism to 
increase in response to hypoxia (9–14). It has been postulated 
that, particularly, glucose uptake might be favorably affected 
by hypoxia (13–17), which has implications for the prevention 
and treatment of disease states, where metabolism is deranged, 
such as in diabetes. Not every study, however, supports that 
view, as decreased skeletal muscle insulin sensitivity (18) and 
impaired lipid metabolism (19) have also been reported after 
chronic hypoxic exposures. Hypoxia also alters adipose tissue 
circulation, which plays an integral role in its metabolism and, 
therefore, has implications for obesity and diabetes.
HYPOXiA AnD ADiPOSe TiSSUe 
CiRCULATiOn AnD MeTABOLiSM
Adipose tissue has an important role in regulating metabolism 
(20–22) – a topic of growing interest as levels of obesity have 
increased globally over the last several decades. Adipose tissue 
vasculature and oxygen supply is an important determinant of 
its  metabolism as well as endocrine function (23, 24). Despite 
the fact that adipose tissue has a capillary surface area less than 
one-third of that in skeletal muscle (24), it has long been acknowl-
edged that also adipocytes are surrounded by an extensive net-
work of capillaries (23). This vascular feature importantly affects 
the adaptability of subcutaneous adipose tissue to excess caloric 
overload, which is known to be associated with a hypoxic state in 
adipose tissue (25–27). Thus, although opposite views have also 
been presented (28), it is the common consensus that due to the 
insufficient blood supply and capillary rarefaction connected with 
tissue inflammation (20, 25, 29–35), chronic low oxygen levels in 
expanded adipose tissue is now well appreciated to contribute to 
metabolic derangements of the whole body.
Although there is also a noticeable extent of variability in 
physiological responses to hypoxia in humans (36), particularly 
white adipose tissue is known to respond remarkably to low 
levels of oxygen. This fact is well illustrated by cell culture 
studies, where exposure of adipocytes to low oxygen levels 
alters the gene expression of over 1000 genes (25). However, no 
change in subcutaneous adipose tissue blood flow is necessarily 
observed at rest in humans in response to moderate systemic 
hypoxia (37). Adipose tissue blood flow in humans is under 
the regulation of the sympathetic nervous system (38), and 
it is, therefore, reasonable to assume that moderate systemic 
hypoxia simply does not create a high enough stimulus for 
sympathetic neural vasoconstrictor activation to reduce blood 
flow in healthy human adipose tissue. On the other hand, it is 
also plausible that the activation of vasoconstriction by arterial 
chemoreceptors predominates over a local hypoxic vasodila-
tion in adipose tissue in humans. In this regard, adipose tissue 
appears to be similar to bone (39). However, increased blood 
flow in response to systemic hypoxia has been documented in 
human skin (40). More studies are clearly warranted to explore 
whether unchanged hypoxic blood flow is also of importance 
to explain pathophysiological characteristics of adipose tissue 
under chronically low oxygen levels that is not compensated by 
increased blood flow (20, 25).
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It is known that subcutaneous adipose tissue blood flow 
increases in response to low intensity exercise, but levels off when 
exercise intensity is further increased (41). Furthermore, at rest, 
but not during exercise, subcutaneous adipose blood flow is under 
the control of nitric oxide (42). In contrast to resting conditions, 
subcutaneous adipose blood flow is reduced during exercise, 
when subjects breathe hypoxic air (37). This novel finding is 
likely based on the constriction of adipose tissue vasculature by 
hypoxia-triggered enhanced sympathetic nervous system activity, 
which redistributes limb blood flow to exercising muscles, which 
depend more critically on adequate oxygen supply in response to 
exercise. In this regard, we have previously reported that blood 
flow in subcutaneous adipose tissue is significantly lowered by 
local infusion of norepinephrine, which is the principal neuro-
transmitter released from the sympathetic nerve endings, and 
that the inhibition of α-adrenergic receptors by phentolamine 
tends to enhance adipose tissue blood flow, both at rest and dur-
ing exercise (38). It has also been previously suggested by Romijn 
et al. (43) that the reduction of adipose tissue blood flow is likely 
to be one important mechanism to explain decreased free-fatty 
acid release in response to high intensity exercise, which then 
leads to preferential utilization of glucose instead of fatty acids 
and contributes to the increased efficiency of ATP generation 
for a limited O2 availability. Additionally, it has been recently 
documented that the inability to increase vascular resistance in 
adipose tissue during exercise or to maintain mean arterial pres-
sure during orthostatic stress in aging is largely a result of reduced 
α-adrenergic responsiveness of adipose tissue arterioles (44, 45). 
Therefore, it is concluded that reduced blood flow in adipose 
tissue is an acute physiological response to diminished oxygen 
availability during exercise, while higher blood flow in adipose 
tissue is needed in response to prolonged exercise that also likely 
associates with higher lipolysis to supply more free-fatty acids into 
circulation to sustain muscular work for prolonged periods (46).
In addition to the general hypoxic responses, the capacity of 
blood flow in human subcutaneous adipose tissue has remained 
largely unexplored, until recently. In this regard, a novel finding 
is that the vasodilatory capacity of human subcutaneous adipose 
tissue determined by infusion of exogenous dilator compounds 
approaches the physiological level reached during moderate 
intensity exercise (37). Furthermore, during this maximal 
vasodilation, vascular conductance can reach a level even higher 
than that induced by exercise. In terms of absolute values, the 
comparison of adipose tissue blood flow capacity to skeletal mus-
cle is also of interest. In this regard, we have previously reported 
that blood flow in human skeletal muscle during a similar phar-
macological vasodilation protocol increases to a level of 40 ml/
min/100 g (47). As the absolute average value of pharmacologi-
cally induced adipose tissue blood flow was 10.5 ml/min/100 g, it 
only reaches ~26% of blood flow level in the muscle. Accordingly, 
the functional vascular capacity appears to be very closely fol-
lowed by that of structural anatomy, as adipose tissue is known 
to have a capillary surface area that is slightly less than one-third 
than that in skeletal muscle (24). In relative terms, blood flow in 
adipose tissue increased 8-fold and blood flow in muscle 14-fold 
in response to pharmacological (adenosine) infusion, and, as 
such, the increase in adipose tissue flow is 57% of that of muscle. 
In contrast to human skeletal muscle (47), pharmacologically 
induced blood flow is not, however, positively and significantly 
related to subjects’ whole body maximal oxygen consumption 
determined in a separate fitness test, indicating that blood flow 
in adipose tissue and muscle do not simply parallel each other. 
Nevertheless, it can be concluded, based on these studies, that 
the functional blood flow capacity of adipose tissue is fairly large 
in healthy human subjects. It remains, however, to be measured 
if this capacity is lost in pathological states. Furthermore, it also 
remains to be determined if a loss of functional vascular capacity 
is linked to impaired fat storage in white adipose tissue which is 
known to contribute to metabolic and cardiovascular derange-
ments in a human body (20).
HYPOXiA AS A TReATMenT OF OBeSiTY 
AnD iMPAiReD ADiPOSe TiSSUe 
PHYSiOLOGY?
As summarized in the beginning of the previous section, it is 
evident that there is a hypoxic state in adipose tissue of obese 
subjects, which may be caused by insufficient circulatory 
responses/adaptations in response to lowered oxygen supply. 
Despite this, chronic and/or intermittent hypoxia has also been 
suggested as treatment option for overweight and obesity (9, 10). 
This is based on findings that hypoxia alters the function of the 
nervous system and hormonal levels such as leptin, which lead 
to changes in glucose metabolism and control of appetite (9–14). 
These physiological responses are enhanced with increasing 
severity of hypoxia, such as altitude exposure. There is evidence 
that people living at high altitude are less likely to be overweight 
and/or obese, the findings which hold after adjustment for many 
plausible confounding factors that might also affect the associa-
tion (48, 49). Protective effects of hypoxia/altitude have also been 
reported in regards to development of diabetes (50) and coronary 
heart disease, as well as stroke (51–53), meaning that hypoxia 
reduced the incidence of these diseases (Table 1). Furthermore, 
interventional trials have been conducted to test the effects 
of hypoxia as a treatment for weight loss and improvement of 
metabolic functions (Table 1). These studies demonstrated that 
7 h of moderate hypoxia under resting conditions did not change 
postprandial glucose responses or substrate oxidation in young 
healthy men (54). However, when hypoxic exposure was com-
bined with low intensity physical activity, Netzer and colleagues 
reported greater weight loss in obese subjects when compared to 
combined exercise and sham hypoxia intervention (55), although 
this finding could not be reproduced in their recent study (56). 
Beneficial effects of hypoxia regarding body weight control have 
also been reported in obese young adults (57). Furthermore, Haufe 
et al. comprehensively investigated numerous cardiovascular risk 
factors in response to hypoxic training and showed favorable 
influences on body fat content, triglycerides, fasting insulin, and 
insulin sensitivity, as compared to exercise training only interven-
tion (58). These findings were confirmed in their later study in 
overweight and obese men with lower exercise workload, which 
reduces exercise burden for overweight subjects and is, thus, ben-
eficial in terms of exercise compliance (59). Appetite regulation is 
TABLe 1 | Summary of studies investigating the effects of hypoxia on cardiovascular and metabolic health in humans.
Reference Type of the study Outcome(s)
Voss et al. (48) Epidemiological Lower rates of new obesity diagnoses among overweight persons at high altitude
Voss et al. (49) Epidemiological Obesity prevalence inversely associated with elevation and urbanization
Woolcott et al. (50) Epidemiological Inverse association between diabetes and altitude
Ezzati et al. (51) Epidemiological Living at higher altitude had a protective effect on ischemic heart disease and a harmful effect on 
chronic obstructive pulmonary disease. No net effect on life expectancy or associations with stroke 
and cancer after adjustments for confounders
Faeh et al. (52) Epidemiological Linearly decreased ischemic heart disease mortality with increasing altitude
Faeh et al. (53) Epidemiological Lower mortality from coronary heart disease and stroke at higher altitudes
Morishima and Goto (54) Acute 7 h experimental trial at rest No effect of hypoxia on postprandial glucose responses or substrate oxidation in young healthy men
Netzer et al. (55) Exercise training in normobaric 
hypoxia
Significantly greater weight loss in obese persons in real hypoxia than in sham hypoxia
Gatterer et al. (56) A randomized, single blind, 
placebo-controlled study
No larger reductions in body weight due to moderate intensity exercise and rest in hypoxia compared 
to normoxia alone in obese subjects
Kong et al. (57) Experimental trial Normobaric hypoxia training caused more weight loss than normoxia training in obese young adults
Haufe et al. (58) Single blind exercise training 
under hypoxia or normoxia
Endurance training in hypoxia resulted in a similar or even better response in terms of cardiovascular 
and metabolic risk factors than endurance exercise in normoxia
Wiesner et al. (59) Single blind exercise training 
under hypoxia or normoxia
Training in hypoxia elicited a similar or even better response in terms of physical fitness, metabolic risk 
markers, and body composition at a lower workload in obese subjects
Debevec et al. (60) Hypoxic confinement at simulated 
altitude with and without daily 
moderate intensity exercise
Body mass decreased in both groups, but whole body fat mass was only reduced in the exercise 
group. No change in hormonal appetite regulation, but improved lipid profile due to combined training 
and hypoxia exposure
Bailey et al. (61) 4-day experimental trial An additive cardioprotective effect of normobaric hypoxia training over training in normoxia
Wee and Climstein (62) A review of 25 hypoxic training trials Hypoxic training may be beneficial as an adjunct treatment to modify some cardiometabolic risk factors
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not necessarily always affected, although lipid profile is improved 
(60). Altogether, it is concluded that training in hypoxia appears 
to have numerous additive and favorable effects on traditional 
cardiovascular risk factors, which may have important clinical 
implications (61, 62).
Despite plausible physiological mechanisms and some 
encouraging results that hypoxia might indeed work as a poten-
tial therapeutic tool to tackle obesity, it may also have detrimental 
influences that need some consideration. First, hypoxia might not 
be well-tolerated by all subjects, as high-altitude illness is expe-
rienced in approximately 10 to 25% of unacclimatized persons 
above 2500  m, and the prevalence and severity of symptoms 
increases with increments in altitude (63). Second, hypoxia is 
associated with impaired cognitive performance, which may 
persist even after the cessation of hypoxic exposure (64). Third, 
hypoxic exposure is known to impair human immune system 
function (65), which may be detrimental in fighting against 
pathogens and other triggers of communicable diseases. Fourth, 
hypoxia is capable of inducing fibrosis in cardiac muscle (66), 
which increases the stiffness of the heart. Many obese individuals 
already have cardiac stiffness (67, 68), which may be exagger-
ated by hypoxic exposure. Finally, as mentioned in the previous 
section, hypoxia triggers an inflammatory response in adipose 
tissue of obese subjects, which may be further exacerbated by 
hypoxia creating a vicious-cycle. Thus, hypoxia not only alters 
human energy metabolism, which may lead to weight loss if not 
compensated for by increased energy intake, but is also capable 
of inducing several physiologically detrimental effects on bodily 
functions. It is likely that the balance of all these determine the 
overall outcome and health effects of hypoxia in humans.
Finally, as hypoxia is indeed a common feature of adipose tissue 
in particular, and potentially other tissues in obese subjects, it has 
been suggested that hyperoxia might be an option to overcome 
the hypoxic state. However, as oxygen is known to be toxic in high 
concentrations, this treatment may not be healthy in terms of cir-
culatory and metabolic function. Hyperoxia is known to decrease 
adipose cell viability, increase both intra- and extracellular oxida-
tive stress, provoke inflammation, and decrease glucose uptake of 
adipocytes (69). Hence, based on this information on hyperoxia 
and reviewed knowledge regarding hypoxia, it is concluded that 
there is a delicate balance of healthy oxygen supply and demand 
in adipose tissue that determines its overall function. While mild 
hypoxia over a sufficient duration of exposure may provide some 
additional benefits, the most feasible approach to address obesity 
and individual weight loss appears to reside in more traditional 
methods proven to be efficient in reducing adipose tissue size: 
physical activity and diet rich in fruits and vegetables, but low in 
caloric energy (Figure 1).
AUTHOR COnTRiBUTiOnS
IH drafted the manuscript and all authors contributed to its revi-
sion and intellectual content.
FUnDinG
The present review was financially supported by The Ministry of 
Education of State of Finland, Academy of Finland, The Finnish 
Cardiovascular Foundation, and The Finnish Diabetes Research 
Foundation.
5Heinonen et al. Hypoxic Responses in Humans
Frontiers in Endocrinology | www.frontiersin.org August 2016 | Volume 7 | Article 116
ReFeRenCeS
1. Weir EK, Lopez-Barneo J, Buckler KJ, Archer SL. Acute oxygen-sensing 
mechanisms. N Engl J Med (2005) 353:2042–55. doi:10.1056/NEJMra050002 
2. Kaijser L, Grubbstrom J, Berglund B. Coronary circulation in acute hypoxia. 
Clin Physiol (1990) 10:259–63. doi:10.1111/j.1475-097X.1990.tb00094.x 
3. Heinonen I, Luotolahti M, Vuolteenaho O, Nikinmaa M, Saraste A, Hartiala J, 
et al. Circulating N-terminal brain natriuretic peptide and cardiac function in 
response to acute systemic hypoxia in healthy humans. J Transl Med (2014) 
12:189. doi:10.1186/1479-5876-12-189 
4. Tune JD. Control of coronary blood flow during hypoxemia. Adv Exp Med Biol 
(2007) 618:25–39. doi:10.1007/978-0-387-75434-5_3 
5. Kaufmann PA, Schirlo C, Pavlicek V, Berthold T, Burger C, von Schulthess 
GK, et al. Increased myocardial blood flow during acute exposure to simulated 
altitudes. J Nucl Cardiol (2001) 8:158–64. doi:10.1067/mnc.2001.112537 
6. Verges S, Rupp T, Jubeau M, Wuyam B, Esteve F, Levy P, et al. Cerebral per-
turbations during exercise in hypoxia. Am J Physiol Regul Integr Comp Physiol 
(2012) 302:R903–16. doi:10.1152/ajpregu.00555.2011 
7. Buck A, Schirlo C, Jasinksy V, Weber B, Burger C, von Schulthess GK, 
et  al. Changes of cerebral blood flow during short-term exposure to 
normobaric hypoxia. J Cereb Blood Flow Metab (1998) 18:906–10. 
doi:10.1097/00004647-199808000-00011 
8. Norcliffe LJ, Rivera-Ch M, Claydon VE, Moore JP, Leon-Velarde F, 
Appenzeller  O, et  al. Cerebrovascular responses to hypoxia and hypocap-
nia in high-altitude dwellers. J Physiol (2005) 566:287–94. doi:10.1113/
jphysiol.2005.086629 
9. Kayser B, Verges S. Hypoxia, energy balance and obesity: from pathophysio-
logical mechanisms to new treatment strategies. Obes Rev (2013) 14:579–92. 
doi:10.1111/obr.12034 
10. Urdampilleta A, Gonzalez-Muniesa P, Portillo MP, Martinez JA. Usefulness 
of combining intermittent hypoxia and physical exercise in the treatment of 
obesity. J Physiol Biochem (2012) 68:289–304. doi:10.1007/s13105-011-0115-1 
11. Yingzhong Y, Droma Y, Rili G, Kubo K. Regulation of body weight by leptin, 
with special reference to hypoxia-induced regulation. Intern Med (2006) 
45:941–6. doi:10.2169/internalmedicine.45.1733 
12. Rose MS, Houston CS, Fulco CS, Coates G, Sutton JR, Cymerman A. 
Operation everest. II: nutrition and body composition. J Appl Physiol (1985) 
(1988) 65:2545–51. 
13. Woolcott OO, Ader M, Bergman RN. Glucose homeostasis during short-term 
and prolonged exposure to high altitudes. Endocr Rev (2015) 36:149–73. 
doi:10.1210/er.2014-1063 
14. Ichiki T, Sunagawa K. Novel roles of hypoxia response system in glucose 
metabolism and obesity. Trends Cardiovasc Med (2014) 24:197–201. 
doi:10.1016/j.tcm.2014.03.004 
15. Heinonen I, Kemppainen J, Kaskinoro K, Peltonen JE, Sipila HT, Nuutila P, 
et al. Effects of adenosine, exercise, and moderate acute hypoxia on energy 
substrate utilization of human skeletal muscle. Am J Physiol Regul Integr Comp 
Physiol (2012) 302:R385–90. doi:10.1152/ajpregu.00245.2011 
16. Rafacho A, Goncalves-Neto LM, Ferreira FB, Protzek AO, Boschero AC, 
Nunes EA, et al. Glucose homoeostasis in rats exposed to acute intermittent 
hypoxia. Acta Physiol (Oxf) (2013) 209:77–89. doi:10.1111/apha.12118 
17. Marquez JL, Rubinstein S, Fattor JA, Shah O, Hoffman AR, Friedlander AL. 
Cyclic hypobaric hypoxia improves markers of glucose metabolism in 
middle-aged men. High Alt Med Biol (2013) 14:263–72. doi:10.1089/
ham.2012.1057 
18. Yu J, Shi L, Wang H, Bilan PJ, Yao Z, Samaan MC, et al. Conditioned medium 
from hypoxia-treated adipocytes renders muscle cells insulin resistant. Eur 
J Cell Biol (2011) 90:1000–15. doi:10.1016/j.ejcb.2011.06.004 
19. Siques P, Brito J, Naveas N, Pulido R, De la Cruz JJ, Mamani M, et al. Plasma 
and liver lipid profiles in rats exposed to chronic hypobaric hypoxia: changes 
in metabolic pathways. High Alt Med Biol (2014) 15:388–95. doi:10.1089/
ham.2013.1134 
20. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. 
J Clin Invest (2011) 121:2094–101. doi:10.1172/JCI45887 
21. Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. 
Physiol Rev (2013) 93:359–404. doi:10.1152/physrev.00033.2011 
22. Feng B, Zhang T, Xu H. Human adipose dynamics and metabolic health. Ann 
N Y Acad Sci (2013) 1281:160–77. doi:10.1111/nyas.12009 
23. Rosell S, Belfrage E. Blood circulation in adipose tissue. Physiol Rev (1979) 
59:1078–104. 
24. Roddie IC. Circulation to skin and adipose tissue. In: Shepherd JT, Abboud 
FM, editors. Handbook of Physiology. Bethesda, MD: American Physiological 
Society (1983). p. 285–317.
25. Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. 
Physiol Rev (2013) 93:1–21. doi:10.1152/physrev.00017.2012 
26. Goossens GH, Blaak EE. Adipose tissue dysfunction and impaired metabolic 
health in human obesity: a matter of oxygen? Front Endocrinol (2015) 6:55. 
doi:10.3389/fendo.2015.00055 
27. Lin Q, Yun Z. The hypoxia-inducible factor pathway in adipocytes: the role 
of HIF-2 in adipose inflammation and hypertrophic cardiomyopathy. Front 
Endocrinol (2015) 6:39. doi:10.3389/fendo.2015.00039 
28. Goossens GH, Bizzarri A, Venteclef N, Essers Y, Cleutjens JP, Konings E, 
et al. Increased adipose tissue oxygen tension in obese compared with lean 
men is accompanied by insulin resistance, impaired adipose tissue capil-
larization, and inflammation. Circulation (2011) 124:67–76. doi:10.1161/
CIRCULATIONAHA.111.027813 
29. Wood IS, de Heredia FP, Wang B, Trayhurn P. Cellular hypoxia and adipose 
tissue dysfunction in obesity. Proc Nutr Soc (2009) 68:370–7. doi:10.1017/
S0029665109990206 
30. Lawler HM, Underkofler CM, Kern PA, Erickson C, Bredbeck B, Rasouli 
N. Adipose tissue hypoxia, inflammation and fibrosis in obese insulin 
sensitive and obese insulin resistant subjects. J Clin Endocrinol Metab (2016) 
101(4):1422–8. doi:10.1210/jc.2015-4125 
31. Spencer M, Unal R, Zhu B, Rasouli N, McGehee RE Jr, Peterson CA, et al. 
Adipose tissue extracellular matrix and vascular abnormalities in obesity and 
insulin resistance. J Clin Endocrinol Metab (2011) 96:E1990–8. doi:10.1210/
jc.2011-1567 
32. Ye J. Adipose tissue vascularization: its role in chronic inflammation. Curr 
Diab Rep (2011) 11:203–10. doi:10.1007/s11892-011-0183-1 
33. Gealekman O, Guseva N, Hartigan C, Apotheker S, Gorgoglione M, Gurav K, 
et al. Depot-specific differences and insufficient subcutaneous adipose tissue 
angiogenesis in human obesity. Circulation (2011) 123:186–94. doi:10.1161/
CIRCULATIONAHA.110.970145 
34. Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, 
et al. Reduced adipose tissue oxygenation in human obesity: evidence for rar-
efaction, macrophage chemotaxis, and inflammation without an angiogenic 
response. Diabetes (2009) 58:718–25. doi:10.2337/db08-1098 
35. Trayhurn P, Alomar SY. Oxygen deprivation and the cellular response to 
hypoxia in adipocytes – perspectives on white and brown adipose tissues in 
obesity. Front Endocrinol (2015) 6:19. doi:10.3389/fendo.2015.00019 
36. Brooks JT, Elvidge GP, Glenny L, Gleadle JM, Liu C, Ragoussis J, et  al. 
Variations within oxygen-regulated gene expression in humans. J Appl Physiol 
(1985) (2009) 106:212–20. doi:10.1152/japplphysiol.90578.2008 
37. Heinonen I, Kemppainen J, Kaskinoro K, Knuuti J, Boushel R, Kalliokoski KK. 
Capacity and hypoxic response of subcutaneous adipose tissue blood flow in 
humans. Circ J (2014) 78:1501–6. doi:10.1253/circj.CJ-13-1273 
38. Heinonen I, Wendelin-Saarenhovi M, Kaskinoro K, Knuuti J, Scheinin M, 
Kalliokoski KK. Inhibition of alpha-adrenergic tone disturbs the distribution 
of blood flow in the exercising human limb. Am J Physiol Heart Circ Physiol 
(2013) 305(2):H163–72. doi:10.1152/ajpheart.00925.2012 
39. Heinonen I, Kemppainen J, Kaskinoro K, Langberg H, Knuuti J, Boushel R, 
et al. Bone blood flow and metabolism in humans: effect of muscular exercise 
and other physiological perturbations. J Bone Miner Res (2013) 28:1068–74. 
doi:10.1002/jbmr.1833 
40. Simmons GH, Minson CT, Cracowski JL, Halliwill JR. Systemic hypoxia causes 
cutaneous vasodilation in healthy humans. J Appl Physiol (2007) 103:608–15. 
doi:10.1152/japplphysiol.01443.2006 
41. Heinonen I, Bucci M, Kemppainen J, Knuuti J, Nuutila P, Boushel R, et  al. 
Regulation of subcutaneous adipose tissue blood flow during exercise 
in humans. J Appl Physiol (1985) (2012) 112:1059–63. doi:10.1152/
japplphysiol.00732.2011 
42. Heinonen I, Saltin B, Kemppainen J, Sipila HT, Oikonen V, Nuutila P, 
et  al. Skeletal muscle blood flow and oxygen uptake at rest and during 
exercise in humans: a pet study with nitric oxide and cyclooxygenase inhi-
bition. Am J Physiol Heart Circ Physiol (2011) 300:H1510–7. doi:10.1152/
ajpheart.00996.2010 
6Heinonen et al. Hypoxic Responses in Humans
Frontiers in Endocrinology | www.frontiersin.org August 2016 | Volume 7 | Article 116
43. Romijn JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E, et al. 
Regulation of endogenous fat and carbohydrate metabolism in relation to 
exercise intensity and duration. Am J Physiol (1993) 265:E380–91. 
44. Davis RT III, Stabley JN, Dominguez JM, Ramsey MW, McCullough DJ, 
Lesniewski LA, et  al. Differential effects of aging and exercise on intra-ab-
dominal adipose arteriolar function and blood flow regulation. J Appl Physiol 
(2013) 114:808–15. doi:10.1152/japplphysiol.01358.2012 
45. Ramsey MW, Behnke BJ, Prisby RD, Delp MD. Effects of aging on adipose 
resistance artery vasoconstriction: possible implications for orthostatic 
blood pressure regulation. J Appl Physiol (2007) 103:1636–43. doi:10.1152/
japplphysiol.00637.2007 
46. Stallknecht B, Lorentsen J, Enevoldsen LH, Bulow J, Biering-Sorensen  F, 
Galbo H, et  al. Role of the sympathoadrenergic system in adipose tissue 
metabolism during exercise in humans. J Physiol (2001) 536:283–94. 
doi:10.1111/j.1469-7793.2001.00283.x 
47. Heinonen I, Kemppainen J, Kaskinoro K, Peltonen JE, Borra R, Lindroos MM, 
et al. Comparison of exogenous adenosine and voluntary exercise on human 
skeletal muscle perfusion and perfusion heterogeneity. J Appl Physiol (2010) 
108:378–86. doi:10.1152/japplphysiol.00745.2009 
48. Voss JD, Allison DB, Webber BJ, Otto JL, Clark LL. Lower obesity rate during 
residence at high altitude among a military population with frequent migra-
tion: a quasi experimental model for investigating spatial causation. PLoS One 
(2014) 9:e93493. doi:10.1371/journal.pone.0093493 
49. Voss JD, Masuoka P, Webber BJ, Scher AI, Atkinson RL. Association of 
elevation, urbanization and ambient temperature with obesity prevalence 
in the United States. Int J Obes (Lond) (2013) 37:1407–12. doi:10.1038/ijo. 
2013.5 
50. Woolcott OO, Castillo OA, Gutierrez C, Elashoff RM, Stefanovski D, Bergman 
RN. Inverse association between diabetes and altitude: a cross-sectional study 
in the adult population of the United States. Obesity (Silver Spring) (2014) 
22:2080–90. doi:10.1002/oby.20800 
51. Ezzati M, Horwitz ME, Thomas DS, Friedman AB, Roach R, Clark T, et al. 
Altitude, life expectancy and mortality from ischaemic heart disease, stroke, 
COPD and cancers: national population-based analysis of US counties. 
J Epidemiol Community Health (2012) 66:e17. doi:10.1136/jech.2010. 
112938 
52. Faeh D, Moser A, Panczak R, Bopp M, Roosli M, Spoerri A, et al. Independent at 
heart: persistent association of altitude with ischaemic heart disease mortality 
after consideration of climate, topography and built environment. J Epidemiol 
Community Health (2016) 70(8):798–806. doi:10.1136/jech-2015-206210 
53. Faeh D, Gutzwiller F, Bopp M; Swiss National Cohort Study Group. 
Lower mortality from coronary heart disease and stroke at higher 
altitudes in Switzerland. Circulation (2009) 120:495–501. doi:10.1161/
CIRCULATIONAHA.108.819250 
54. Morishima T, Goto K. Successive exposure to moderate hypoxia does not 
affect glucose metabolism and substrate oxidation in young healthy men. 
Springerplus (2014) 3:370. doi:10.1186/2193-1801-3-370 
55. Netzer NC, Chytra R, Kupper T. Low intense physical exercise in normobaric 
hypoxia leads to more weight loss in obese people than low intense phys-
ical exercise in normobaric sham hypoxia. Sleep Breath (2008) 12:129–34. 
doi:10.1007/s11325-007-0149-3 
56. Gatterer H, Haacke S, Burtscher M, Faulhaber M, Melmer A, Ebenbichler C, 
et al. Normobaric intermittent hypoxia over 8 months does not reduce body 
weight and metabolic risk factors – a randomized, single blind, placebo- 
controlled study in normobaric hypoxia and normobaric sham hypoxia. Obes 
Facts (2015) 8:200–9. doi:10.1159/000431157 
57. Kong Z, Zang Y, Hu Y. Normobaric hypoxia training causes more weight 
loss than normoxia training after a 4-week residential camp for obese 
young adults. Sleep Breath (2014) 18:591–7. doi:10.1007/s11325-013- 
0922-4 
58. Haufe S, Wiesner S, Engeli S, Luft FC, Jordan J. Influences of normobaric 
hypoxia training on metabolic risk markers in human subjects. Med Sci Sports 
Exerc (2008) 40:1939–44. doi:10.1249/MSS.0b013e31817f1988 
59. Wiesner S, Haufe S, Engeli S, Mutschler H, Haas U, Luft FC, et al. Influences 
of normobaric hypoxia training on physical fitness and metabolic risk markers 
in overweight to obese subjects. Obesity (Silver Spring) (2010) 18:116–20. 
doi:10.1038/oby.2009.193 
60. Debevec T, Simpson EJ, MacDonald IA, Eiken O, Mekjavic IB. Exercise train-
ing during normobaric hypoxic confinement does not alter hormonal appetite 
regulation. PLoS One (2014) 9:e98874. doi:10.1371/journal.pone.0098874 
61. Bailey DM, Davies B, Baker J. Training in hypoxia: modulation of metabolic 
and cardiovascular risk factors in men. Med Sci Sports Exerc (2000) 32:1058–66. 
doi:10.1097/00005768-200006000-00004 
62. Wee J, Climstein M. Hypoxic training: clinical benefits on cardiometabolic 
risk factors. J Sci Med Sport (2015) 18:56–61. doi:10.1016/j.jsams.2013.10.247 
63. Bartsch P, Swenson ER. Acute high-altitude illnesses. N Engl J Med (2013) 
368:2294–302. doi:10.1056/NEJMcp1214870 
64. Yan X. Cognitive impairments at high altitudes and adaptation. High Alt Med 
Biol (2014) 15:141–5. doi:10.1089/ham.2014.1009 
65. Oliver SJ, Macdonald JH, Harper Smith AD, Lawley JS, Gallagher CA, Di FU, 
et al. High altitude impairs in vivo immunity in humans. High Alt Med Biol 
(2013) 14:144–9. doi:10.1089/ham.2012.1070 
66. Watson CJ, Collier P, Tea I, Neary R, Watson JA, Robinson C, et al. Hypoxia-
induced epigenetic modifications are associated with cardiac tissue fibrosis 
and the development of a myofibroblast-like phenotype. Hum Mol Genet 
(2014) 23:2176–88. doi:10.1093/hmg/ddt614 
67. Goncalves N, Silva AF, Rodrigues PG, Correia E, Moura C, Eloy C, et  al. 
Early cardiac changes induced by a hypercaloric diet in “subclinical” 
obesity. Am J Physiol Heart Circ Physiol (2016) 15:H655–66. doi:10.1152/
ajpheart.00684.2015 
68. Leopoldo AS, Sugizaki MM, Lima-Leopoldo AP, do Nascimento AF, 
Luvizotto  RA, de Campos DH, et  al. Cardiac remodeling in a rat model 
of diet-induced obesity. Can J Cardiol (2010) 26:423–9. doi:10.1016/
S0828-282X(10)70440-2 
69. Quintero P, Gonzalez-Muniesa P, Garcia-Diaz DF, Martinez JA. Effects of 
hyperoxia exposure on metabolic markers and gene expression in 3T3-L1 adi-
pocytes. J Physiol Biochem (2012) 68:663–9. doi:10.1007/s13105-012-0169-8 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
The reviewer MH and handling Editor declared their shared affiliation, and the 
handling Editor states that the process nevertheless met the standards of a fair and 
objective review.
Copyright © 2016 Heinonen, Boushel and Kalliokoski. This is an open-access article 
distributed under the terms of the Creative Commons Attribution License (CC BY). 
The use, distribution or reproduction in other forums is permitted, provided the 
original author(s) or licensor are credited and that the original publication in this 
journal is cited, in accordance with accepted academic practice. No use, distribution 
or reproduction is permitted which does not comply with these terms.
